Specgx LLC
General
Total Cases5
Active Cases1
Patents7
--
--
--
Ratings
Experience
Grade
Trend
DCT
L3
A
PTAB
L5
A
CAFC
L3
E
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 08/14/24 | WAIVER OF SERVICE returned executed by PBG Puerto Rico LLC, PF PRISM C.V., C.P. Pharmaceuticals International C.V., PF PRISM IMB B.V., Pfizer Inc.: For SpecGx LLC waiver sent on 8/12/2024, answer due 10/11/2024. (Dellinger, Megan) (Entered: 08/14/2024) | |
| 08/14/24 | STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf) (Entered: 08/14/2024) | |
| 08/14/24 | Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) (Entered: 08/14/2024) | |
| 08/09/24 | Summons Issued as to SpecGx LLC on 8/9/2024. (oam) (Entered: 08/09/2024) | |
| 08/09/24 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V. filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc. (oam) (Entered: 08/09/2024) | |
| 08/09/24 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE41,783 E. (oam) (Entered: 08/09/2024) | |
| 08/09/24 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 06/26/2024. Date of Expiration of Patent: 12/08/2025. Thirty Month Stay Deadline: See Attached. (oam) (Entered: 08/09/2024) | |
| 08/09/24 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 06/26/2024. Date of Expiration of Patent: Upon Expiration of the patent. (oam) (Entered: 08/09/2024) | |
| 08/09/24 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) (Entered: 08/09/2024) | |
| 08/09/24 | COMPLAINT for ANDA/PATENT INFRINGEMENT file against SpecGx LLC ( Filing fee $ 405, receipt number ADEDC-4472322.) - filed by Pfizer Inc., C.P. Pharmaceuticals International C.V., PF PRISM C.V., BG Puerto Rico LLC, PF PRISM IMB B.V.(Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(oam) (Entered: 08/09/2024) |